D-0140-2020 Class II Terminated
FDA drug recall D-0140-2020 was initiated by Macleods Pharma Usa Inc on Sep 23, 2019 and is designated Class II. Reason for recall: Superpotent The recall status is terminated (terminated Feb 23, 2021). Affected quantity: 31,968 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Oct 23, 2019
- Initiation Date
- Sep 23, 2019
- Termination Date
- Feb 23, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 31,968 bottles
Product description
Pioglitazone Hydrochloride Tablets USP 15 mg, 30 count bottles, Rx only, Manufactured for: Macleods Pharma USA, Inc., Plainsboro, NJ, Manufactured by: Macleods Pharmaceuticals Ltd., Baddi, Himachal Pradesh, India NDC 33342-054-07
Reason for recall
Superpotent
Distribution pattern
Product was shipped to 8 distributors who may have further distributed the product.
Code information
Lot # BPF901A, exp. date 12/2021
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0140-2020
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026